Improving the physicochemical and pharmacokinetic properties of olaparib through cocrystallization strategy.

Olaparib (OLA) is the first PARP inhibitor worldwide used for the treatment of ovarian cancer. However, the oral absorption of OLA is extremely limited by its poor solubility. Herein, pharmaceutical cocrystallization strategy was employed to optimize the physicochemical and pharmacokinetic properties. Four cocrystals of OLA with oxalic acid (OLA-OA), malonic acid (OLA-MA), fumaric acid (OLA-FA) and maleic acid (OLA-MLA) were successfully discovered and characterized. Fourier transform infrared spectroscopy and X-ray photoelectron spectroscopy confirmed the formation of cocrystals rather than salts, and the possible hydrogen bonding patterns were analyzed through molecular surface electrostatic potential calculations. The in vitro and in vivo evaluations indicate that all of the cocrystals demonstrate significantly improved dissolution performance, oral absorption and tabletability compared to pure OLA. Among them, OLA-FA exhibit sufficient stability and the most increased Cmax and AUC0-24h values that were 11.6 and 6.1 times of free OLA, respectively, which has great potential to be developed into the improved solid preparations of OLA.

Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery.

Hepatocellular carcinoma (HCC) is a highly prevalent and lethal tumor worldwide and its late discovery and lack of effective specific therapeutic agents necessitate further research into its pathogenesis and treatment. Organoids, a novel model that closely resembles native tumor tissue and can be cultured in vitro, have garnered significant interest in recent years, with numerous reports on the development of organoid models for liver cancer. In this study, we have successfully optimized the procedure and established a culture protocol that enables the formation of larger-sized HCC organoids with stable passaging and culture conditions. We have comprehensively outlined each step of the procedure, covering the entire process of HCC tissue dissociation, organoid plating, culture, passaging, cryopreservation, and resuscitation, and provided detailed precautions in this paper. These organoids exhibit genetic similarity to the original HCC tissues and can be utilized for diverse applications, including the identification of potential therapeutic targets for tumors and subsequent drug development.

Hematodinium spp. infections in wild and cultured populations of marine crustaceans along the coast of China.

The parasitic dinoflagellate Hematodinium spp. infects a broad range of marine crustaceans. Its epidemics have impacted wild populations of various commercial fishery species around the world and the sustainability of mariculture in China. To study the epidemiology of Hematodinium spp. in marine crustaceans along the coast of China, we conducted a broad survey of wild and cultured stocks of major crustacean species in 2013 to 2015. Hematodinium sp. infections were identified in wild stocks of Portunus trituberculatus from Huludao, Laizhou, Qingdao, Yangtze River Estuary and Zhoushan, and Scylla paramamosain from Shantou; and cultured stocks of Portunus trituberculatus and Penaeus monodon from a polyculture pond in Qingdao. In the polyculture pond, Hematodinium sp. infections were observed in Portunus trituberculatus from June until October, with peak prevalence (up to 90%) observed in late July to early August. Furthermore, Hematodinium sp. infection was identified for the first time in the giant tiger prawn Penaeus monodon in the polyculture system during the disease outbreak. Phylogenetic analysis indicated that the Hematodinium isolate infecting Penaeus monodon was identical to the isolate infecting the co-cultured Portunus trituberculatus, and it was grouped into H. perezi genotype II together with the other isolates reported in China. The Hematodinium sp. isolated from Portunus trituberculatus appeared to have similar life stages as the H. perezi genotype III isolated from the American blue crab Callinectes sapidus. Our study indicates that outbreaks of Hematodinium disease can be a significant threat to the widely used polyculture system for decapods in China that may be particularly vulnerable to such generalist pathogens.

Synthesis and in vitro antiproliferative evaluation of novel nonsymmetrical disulfides bearing 1,3,4-oxadiazole moiety.

A series of novel nonsymmetrical disulfides bearing 1,3,4-oxadiazole moiety were designed, synthesized and evaluated for their in vitro antiproliferative activities against SMMC-7721, Hela and A549 human cancer cell lines by CCK-8 assay. The preliminary bioassay results demonstrated that all tested compounds 7a-7o exhibited antiproliferation with different degrees, and some compounds showed better effects than positive control 5-fluorouracil against various cancer cell lines. Among these compounds, compound 7j showed significant antiproliferative activity against SMMC-7721 cells with IC50 value of 3.40µM. Compound 7a displayed highly effective biological activity against Hela cells with IC50 value of 4.26µM. Compound 7g exhibited the best inhibitory effect against A549 cells with IC50 value of 6.26µM.

Synthesis and antitumor-evaluation of 1,3-selenazole-containing 1,3,4-thiadiazole derivatives.

A series of novel 1,3-selenazole-containing 1,3,4-thiadiazole derivatives bearing Schiff base moieties were synthesized and evaluated for their in vitro antiproliferative activities against human breast cancer cell MCF-7 and mouse lymphocyte leukemia cell L1210 by CCK-8 assay. The majority of the compounds showed better activity against MCF-7 cell, compared with lead compound PCS. In particular, compound 6c was the most potent compound with IC50 value of 4.02 µM.

Synthesis and in vitro antitumor activity of 1,3,4-oxadiazole derivatives based on benzisoselenazolone.

A series of novel 1,3,4-oxadiazole derivatives based on benzisoselenazolone has been prepared and tested for antiproliferative activity in vitro against the cells of human cancer cell lines: SSMC-7721 (human liver cancer cell), MCF-7 (human breast cancer cell) and A549 (human lung cancer cell). All the compounds obtained exhibited antiproliferative activity and showed selective cytotoxicity against different cancer cells. Compounds 7d and 7i showed significant antiproliferative activities against MCF-7 cells, with IC50 values of 1.07 and 1.76 µM respectively. Compound 7d were found to be the most potent compound against SSMC-7721 cells, with IC50 values 4.46 µM.